Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/26341Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Klein, Oliver | - |
| dc.contributor.author | Kee, Damien | - |
| dc.contributor.author | Markman, Ben | - |
| dc.contributor.author | Carlino, Matteo S | - |
| dc.contributor.author | Underhill, Craig | - |
| dc.contributor.author | Palmer, Jodie | - |
| dc.contributor.author | Power, Daniel | - |
| dc.contributor.author | Cebon, Jonathan S | - |
| dc.contributor.author | Behren, Andreas | - |
| dc.date | 2021-05-10 | - |
| dc.date.accessioned | 2021-05-03T05:19:35Z | - |
| dc.date.available | 2021-05-03T05:19:35Z | - |
| dc.date.issued | 2021-04-29 | - |
| dc.identifier.citation | Cancer Cell 2021; 39(5): 592-593 | en |
| dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/26341 | - |
| dc.language.iso | eng | |
| dc.title | Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1/CTLA-4 combination immunotherapy. | en |
| dc.type | Journal Article | en |
| dc.identifier.journaltitle | Cancer Cell | en |
| dc.identifier.affiliation | Albury-Wodonga Regional Cancer Centre, Albury-Wodonga, Australia | en |
| dc.identifier.affiliation | Monash University, Melbourne, Australia | en |
| dc.identifier.affiliation | Department of Medical Oncology, Alfred Health, Melbourne, Australia | en |
| dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute | en |
| dc.identifier.affiliation | Blacktown Hospital and the University of Sydney, Sydney, Australia | en |
| dc.identifier.affiliation | Department of Medical Oncology, Peter McCallum Cancer Centre, Melbourne, Australia | en |
| dc.identifier.affiliation | Medical Oncology | en |
| dc.identifier.affiliation | School of Cancer Medicine, La Trobe University, Australia | en |
| dc.identifier.affiliation | ThermoFisher Scientific Ltd | en |
| dc.identifier.doi | 10.1016/j.ccell.2021.04.005 | en |
| dc.type.content | Text | en |
| dc.identifier.pubmedid | 33930312 | |
| local.name.researcher | Cebon, Jonathan S | |
| item.languageiso639-1 | en | - |
| item.openairetype | Journal Article | - |
| item.cerifentitytype | Publications | - |
| item.fulltext | No Fulltext | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.grantfulltext | none | - |
| crisitem.author.dept | Medical Oncology | - |
| crisitem.author.dept | Medical Oncology | - |
| crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
| crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
| Appears in Collections: | Journal articles | |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.